Tetracycline is NOT recommended for treating chlamydia—use doxycycline or azithromycin instead.
While tetracycline is technically active against Chlamydia trachomatis 1, it is not included in any CDC treatment guidelines as a recommended or alternative regimen for chlamydia infection. The most recent CDC guidelines consistently recommend doxycycline 100 mg orally twice daily for 7 days or azithromycin 1 g orally as a single dose as first-line therapy 2, 3, 4.
Why Doxycycline, Not Tetracycline?
Doxycycline has replaced tetracycline as the tetracycline-class drug of choice for several practical reasons:
- Simpler dosing: Doxycycline requires only twice-daily dosing versus tetracycline's four-times-daily regimen 5
- Better compliance: Less frequent dosing improves adherence, which is critical for cure and preventing complications like pelvic inflammatory disease, ectopic pregnancy, and infertility 3, 4
- Equivalent efficacy: Doxycycline achieves 95-98% microbiological cure rates 3, 6
- Lower cost than alternatives: While more expensive than generic tetracycline historically, doxycycline remains cost-effective 3
Current Treatment Algorithm
For non-pregnant adults and adolescents:
- First-line: Doxycycline 100 mg PO twice daily for 7 days OR Azithromycin 1 g PO single dose 3
- Alternative regimens: Erythromycin base 500 mg PO four times daily for 7 days, Levofloxacin 500 mg PO daily for 7 days, or Ofloxacin 300 mg PO twice daily for 7 days 3, 4
For pregnant women (where doxycycline is contraindicated):
- Erythromycin base 500 mg PO four times daily for 7 days OR Amoxicillin 500 mg PO three times daily for 7 days 7
- Azithromycin 1 g single dose is now more widely accepted 3
Key Clinical Considerations
Choose azithromycin over doxycycline when:
- Compliance is questionable (single directly observed dose) 3, 4
- Patient has erratic healthcare-seeking behavior 3
- Immediate treatment completion is needed 4
Choose doxycycline when:
Important Caveats
- No test-of-cure needed after doxycycline or azithromycin unless symptoms persist or reinfection suspected 3, 4
- Rescreen in 3 months: High reinfection rates (18-29%) occur due to untreated partners or new exposures 4, 8
- Treat partners simultaneously: All sexual contacts within 60 days must be treated to prevent reinfection 3, 7
- Abstain from sex for 7 days after single-dose therapy or until completion of 7-day regimen 3
The Bottom Line
Tetracycline is obsolete for chlamydia treatment in modern practice. While it has microbiological activity against C. trachomatis 1, its four-times-daily dosing makes it impractical and inferior to doxycycline for achieving the treatment adherence necessary to prevent serious reproductive complications 3, 5. The most recent European guidelines (2025) also recommend doxycycline as first-line over azithromycin due to emerging concerns about azithromycin resistance 9.